Accessibility Menu
Lonza Group Ag logo

Lonza Group Ag(OTC) LZAGY

Market Cap$51.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+859%
5 Year-8%
1 Year+7%
1 Month+12%
$73.87
+1.22%
+0.89Today
Lonza Group Ag last closing stock price
MetricPriceDate
Last closeUSD 73.872026-08-21
Lonza Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.9%USD 69.102026-08-14
1 month+12.38%USD 65.732026-07-22
3 month+17.55%USD 62.842026-05-22
Year to date+10.96%USD 66.572025-12-31
1 year+6.51%USD 69.362025-08-21
3 year+42.42%USD 51.872023-08-22
5 year-8.27%USD 80.532021-08-20
Since inception+859.19%USD 7.702008-10-16

Lonza Group Ag Financials at a Glance

Market Cap

$51.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 13.49B

Net Income (TTM)

CHF 1.86B

EPS (TTM)

-$0.18

P/E Ratio

-421.87

Dividend

$0.32

Beta (Volatility)

0.80 (Low)

Price

$73.87

Volume

23,419

Open

$73.33

Previous Close

$73.87

Daily Range

$73.25 - $74.00

52-Week Range

$58.53 - $74.00

Estimated Earnings Date

Jul 22, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lonza Group Ag

Lonza Group AG is a leading global provider of pharmaceutical, healthcare, and life science products. The company operates through various segments, including Biologics, Small Molecules, Cell and Gene, and Capsule and Health Ingredients, catering to diverse client needs across the product lifecycle.

Products and Services
  • Biologics: Contract development and manufacturing for biopharmaceuticals
  • Small Molecules: Integrated drug substance and product solutions
  • Cell and Gene: Development and commercialization of emerging therapies
Growth Outlook
  • Revenue of CHF 3.45 billion in Q2 2026, showing strong demand
  • Operating income margin of 23.9% indicates efficient operations
  • Continued investment in R&D to drive innovation and market expansion
Financial Highlights
  • Net income of CHF 603.7 million in Q2 2026, reflecting robust profitability
  • Gross profit margin of 38.4% demonstrates strong pricing power
  • Cash flow from operations of CHF 674.2 million supports financial stability
Lonza Group AG has established itself as a key player in the biotechnology sector, leveraging its extensive expertise to meet the evolving needs of the pharmaceutical and healthcare industries. The company's diverse product offerings and commitment to innovation position it well for future growth. Recent financial performance highlights, including a significant revenue increase and strong operating margins, underscore the company's operational efficiency and market strength. With ongoing investments in research and development, Lonza is poised to capitalize on emerging opportunities in the life sciences sector, making it an attractive consideration for potential investors.
AI Generated • Aug 19, 2026

Industry

Life Sciences Tools and Services

Employees

16,866

CEO

Wolfgang Wienand, PhD

Headquarters

Basel, BS 4002, CH

LZAGY Financials

Key Financial Metrics (TTM)

Gross Margin

35.79%

Operating Margin

23.02%

Net Income Margin

-1.74%

Return on Equity

-1.28%

Return on Capital

9.65%

Return on Assets

-0.60%

Earnings Yield

-0.24%

Dividend Yield

0.43%

Payout Ratio

-3.39%

Stock Overview

Market Cap

$51.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

698.44M

Volume

23.42K

Avg. Volume

48.97K

Financials (TTM)

Gross Profit

CHF 4.68B

Operating Income

CHF 2.57B

EBITDA

CHF 3.79B

Operating Cash Flow

CHF 2.61B

Capital Expenditure

-CHF 2.75B

Free Cash Flow

-CHF 147.56M

Cash & ST Invst.

CHF 487.00M

Total Debt

CHF 4.17B

Lonza Group Ag Performance Analysis

Lonza Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 6,515,786,09010.1%
20232023-12-31CHF 7,474,530,58714.7%
20242024-12-31CHF 6,222,552,302-16.7%
20252025-12-31CHF 7,864,067,67926.4%
Lonza Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3115.0%
Q22025-06-301.7%
Q42025-12-31-17.4%
Q22026-06-3016.6%
Lonza Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 1.71-60.4%
20232023-12-31CHF 0.99-42.3%
20242024-12-31CHF 1.012.6%
20252025-12-31CHF -0.47N/A
Lonza Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-6.9%
Q22025-06-3041.5%
Q42025-12-3122.7%
Q22026-06-3015.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 3.45B

+12.7%

Gross Profit

CHF 1.32B

+18.5%

Gross Margin

38.38%

N/A

Market Cap

$51.59BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.06M

N/A

Employees

16,866

N/A

Net Income

CHF 603.71M

+83.5%

EBITDA

CHF 1.17B

+41.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 487.00M

-75.9%

Total Debt

CHF 4.17B

+9.8%

Accounts Receivable

CHF 1.92B

+23.8%

Inventory

CHF 1.88B

+9.7%

Long Term Debt

CHF 3.39B

-6.8%

Short Term Debt

CHF 774.00M

+399.4%

Return on Assets

-0.60%

N/A

Return on Invested Capital

10.34%

N/A

Free Cash Flow

CHF 82.74M

+170.7%

Operating Cash Flow

CHF 674.20M

+33.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UCBJFUCB S.A.
$263.09+1.54%
UCBJYUCB S.A.
$129.23+2.47%
HOCPFHOYA Corporation
$163.45+0.00%
HLNCFHaleon plc
$4.81-0.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$120.60-0.01%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$47.03+0.02%
IBITiShares Bitcoin Trust
$43.68+0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.17+0.01%

Questions About LZAGY

What is the current price of Lonza Group Ag?

Lonza Group Ag is trading at $73.87 per share.

What is the 52-week range for Lonza Group Ag?

Over the past 52 weeks, Lonza Group Ag has traded between $58.53 and $74.00.

How much debt does Lonza Group Ag have?

As of the most recent reporting period, Lonza Group Ag reported total debt of CHF 5.73B.

How much cash does Lonza Group Ag have on hand?

Lonza Group Ag reported CHF 907.54M in cash and cash equivalents in its most recent financial results.

What is Lonza Group Ag’s dividend yield?

Lonza Group Ag currently has a dividend yield of 0.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.